185 related articles for article (PubMed ID: 6701471)
1. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
Johnson E; Eskeland T; Bertheussen K
Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
[TBL] [Abstract][Full Text] [Related]
2. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
3. Species specificity of recognition by the alternative pathway of complement.
Horstmann RD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis by human monocytes of unopsonized particulate activators of the human alternative complement pathway: induction by cytokine.
Chakravarti B; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1986 Aug; 137(3):880-6. PubMed ID: 3088115
[TBL] [Abstract][Full Text] [Related]
5. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
[TBL] [Abstract][Full Text] [Related]
6. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
7. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR
J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
Bohnsack JF; O'Shea JJ; Takahashi T; Brown EJ
J Immunol; 1985 Oct; 135(4):2680-6. PubMed ID: 3161946
[TBL] [Abstract][Full Text] [Related]
10. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
Ross GD; Lambris JD
J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
[TBL] [Abstract][Full Text] [Related]
11. Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.
Czop JK; Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3831-5. PubMed ID: 278997
[TBL] [Abstract][Full Text] [Related]
12. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
13. A molecular basis of activation of the alternative pathway of human complement.
Austen KF; Fearon DT
Adv Exp Med Biol; 1979; 120B():3-17. PubMed ID: 390986
[TBL] [Abstract][Full Text] [Related]
14. Attachment and phagocytosis by salmon macrophages of agarose beads coated with human C3b and C3bi.
Johnson E; Smith P
Dev Comp Immunol; 1984; 8(3):623-30. PubMed ID: 6238856
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
Meri S; Pangburn MK
Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
[TBL] [Abstract][Full Text] [Related]
16. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
17. Formation of the functional alternative pathway of complement by human monocytes in vitro as demonstrated by phagocytosis of agarose beads.
Hetland G; Eskeland T
Scand J Immunol; 1986 Mar; 23(3):301-8. PubMed ID: 3952470
[TBL] [Abstract][Full Text] [Related]
18. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
19. Complement (C3) receptor-mediated attachment of agarose beads to mouse peritoneal macrophages and human monocytes.
Johnson E; Bøgwald J; Eskeland T; Seljelid R
Scand J Immunol; 1983 May; 17(5):403-10. PubMed ID: 6222469
[TBL] [Abstract][Full Text] [Related]
20. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
